Navigation Links
Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies
Date:4/21/2009

tist and lead author of the study. "In data presented at this conference last year, we demonstrated that our fully human antibody PGN635 localizes to tumors and causes an increase in several inflammatory cytokines while decreasing an important anti-inflammatory cytokine. The new data we present confirms that PGN635 also triggers immune cells to produce other chemokines and cytokines that have the potential to alter the suppressed immune environment commonly found in tumors, attracting additional immune cells and stimulating more aggressive anti-tumor responses. We believe this upregulation of the immune response contributes to the encouraging anti-tumor effects demonstrated by PGN635 and other anti-PS antibodies."

A second study(2) presented on Monday by researchers from UT Southwestern Medical Center and Affitech demonstrated the ability of Peregrine's fully human PS-targeting antibody PGN632 to promote the maturation of dendritic cells, important antigen-presenting cells of the immune system. In the in vitro studies, immature dendritic cells cultured in the presence of PGN632 exhibited a significant increase in the production of inflammatory cytokines and chemokines. PGN632 also induced an increase in the expression of cell-surface molecules that are indicative of mature dendritic cells and that assist in antigen presentation functions, as well as in stimulating T-cell proliferation.

Dr. Xianming Huang, assistant professor of pharmacology at UT Southwestern Medical Center and lead author of the study, noted, "Dendritic cells are the professional antigen-presenting cells of the immune system and they play a crucial role in initiating adaptive immune responses. Dendritic cells must be mature, or activated, to be effective, yet tumors and other pathogens such as viruses often possess the ability to undermine this maturation, thereby suppressing the immune response. The results presented today suggest that by blocking e
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
6. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
7. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
8. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
9. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
10. Oridion Announces Significant Medical Studies Presented at STA
11. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... manufacturer of advanced cell imaging systems, announced today that ... Morgan Healthcare Conference. The Conference will be held January ... Francisco. David Basiji, Ph.D., Amnis, President and Chief ... 2:30 PM in Room F and will discuss the ... future products and novel in vitro diagnostic applications. ...
(Date:12/17/2009)... Just how much exposure to radiation ... do those working with patients in the CT ... over exposure? Veteran-owned RADeCO Health, Inc. of Sandwich, ... of the RADView(TM) CT dosimeter, a new monitoring ... Computed Tomography (CT) scans of patients. ,, ...
(Date:12/17/2009)... Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced today ... for an exclusive licensing option to a set ... that can form the basis of a novel ... platform mitochondrial mutation detection technology will be evaluated ... evaluates and quantitates the presence of low-level mitochondrial ...
Breaking Medicine Technology:Revolutionary Radiation Monitoring Device for CT Scans 2Revolutionary Radiation Monitoring Device for CT Scans 3Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 2Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 3Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 4Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 1Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 3Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2First genetically engineered malaria vaccine to enter human trials 13267 1First genetically engineered malaria vaccine to enter human trials 13267 2
(Date:12/17/2009)... help lengthen long bones in the arms and legs in order ... Because the device is completely internal, patients can remain mobile while ... , ... (PRWEB) December 17, 2009 -- ... at Park Meadows Cosmetic Surgery in Lone Tree, Colorado, ...
(Date:12/17/2009)... a common scenario. A pregnant woman, who has carefully examined her ... a birth plan – realizes that her healthcare provider is not ... plan does not match her provider’s practice style. , ... ... common scenario. A pregnant woman, who has carefully examined her options ...
(Date:12/17/2009)... (TWSHF) was established in 2003 to make current information on ... and to healthcare professionals. Following a careful review of ... voted to dissolve the non-profit and donate its assets to ... ... Cincinnati, OH (PRWEB) December 17, 2009 -- The Women,s Sexual ...
(Date:12/17/2009)... funding needed for continued success , ... Washington, DC ... Health Organization,s World Malaria Report 2009 released earlier ... the study have witnessed reduction in malaria cases by more than ... information gathered from malaria programs in 108 countries, highlights considerable progress ...
(Date:12/17/2009)... Creek plastic surgeon and facial aesthetics specialist offers a discount certificate ... ... Denver, CO (PRWEB) December 17, 2009 -- Jeffrey R. Raval, ... Aesthetics, P.C. and Rocky Mountain Laser Aesthetics in Cherry Creek North, ... and purchase a Gift Certificate for $100 in services or ...
Breaking Medicine News(10 mins):Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 2Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 3Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 2Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 3Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 2Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 3Health News:WHO World Malaria Report Shows Aid Efforts Are Working 2Health News:WHO World Malaria Report Shows Aid Efforts Are Working 3Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 2Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 3
... People with gum disease are more likely to suffer from ... to heart attack // or stroke shows latest research . ... in the mouths of 657 people who had no history ... carotid artery, used to identify atherosclerosis, was also measured. People ...
... a recent study researchers say , cancer patients have ... blood clots in the legs or lungs. ,Researchers ... a blood clot in their legs or lungs. They ... and carrier status of gene mutations. Patients underwent anticoagulant ...
... the fiber intake among kids shows , most small children between ... diets thereby putting them at higher risk for health problems like ... survey, conducted between 1994 and 1996 and in 1998, on dietary ... 2 and 5. Results showed most kids got what fiber they ...
... of oxygen can have a reduced risk of brain damage ... 72 hours after birth according to a recent study. ... the brain during delivery showed signs of being at a ... does not happen immediately when babies are oxygen-deprived instead, researchers ...
... comparative energetics of both lean and obese adults to ... that NEAT -- non-exercise activity thermogenesis , creates a ... calories people burn during everyday activities are more important ... average, about 150 minutes more each day and burn ...
... Bio probe being developed, screening women for cervical cancer could ... inserted into the vagina, and the woman herself can do ... measures electrical resistance. ,It is so small that ... than taking up the routine Pap smear that is being ...
Other Medicine News:
... Leica ASP200 is an advanced smart processor ... and routine histopathology applications. Proven and enhanced ... smart operating software are the hallmark of ... simplified and the software includes a variety ...
... A unique sliding microtome with ... during return travel. Maintenance-free precision cross ... specimens and specialty applications in biological, ... up to 155 x 90 mm ...
... precision as well as outstanding ergonomic characteristics. ... an eclusive design feature of MICROM. Moreover, ... during return travel, quick trim feature at ... counter. With these microtome, MICROM sets new ...
... heavy-duty sectioning system is the standard microtome for ... real working animal. ,Large specimens up to 250 ... bone or teeth and whole organs (brain, lung, ... accessories, specially designed for paraffin and resin embedded ...
Medicine Products: